Literature DB >> 34755343

Insight of oral vaccines as an alternative approach to health and disease management: An innovative intuition and challenges.

Nabendu Debnath1, Mony Thakur2, Neelam P Negi3, Vibhav Gautam4, Ashok Kumar Yadav1, Deepak Kumar5.   

Abstract

Vaccination is the most suitable and persuasive healthcare program for the prohibition of various deadly diseases. However, the higher production cost and purification strategies are out of reach for the developing nations. In this scenario, development of edible vaccine turns out to be the most promising alternative for remodeling the pharmaceutical industry with reduced production and purification costs. Generally, oral route of vaccination is mostly preferred due to its safety, compliance, low manufacturing cost and most importantly the ability to induce immunity in both systemic and mucosal sites. Genetically modified microorganisms and plants could efficiently be used as vehicles for edible vaccines. Edible vaccines are supposed to reduce the risk associated with traditional vaccines. Currently, oral vaccines are available in the market for several viral and bacterial diseases like cholera, hepatitis B, malaria, rabies etc. Herein, the review focuses on the breakthrough events in the area of edible vaccines associated with dietary microbes and plants for better control over diseases.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  edible vaccine; genetically modified plants; immune response; mucosal immunity; transgenic bacteria

Mesh:

Substances:

Year:  2021        PMID: 34755343     DOI: 10.1002/bit.27987

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  2 in total

1.  Orally Administrated Recombinant Vaccinia Virus Displaying ROP4 Induces Protection against Toxoplasma gondii Challenge Infection.

Authors:  Keon-Woong Yoon; Ki-Back Chu; Hae-Ji Kang; Min-Ju Kim; Gi-Deok Eom; Fu-Shi Quan
Journal:  Vaccines (Basel)       Date:  2022-01-20

Review 2.  Probiotics as multifaceted oral vaccines against colon cancer: A review.

Authors:  Shubhi Singh; Manisha Singh; Smriti Gaur
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.